Dermira, Inc. (DERM) Stock: Here’s What Investors Need to Know


The social media is heating up with regard to Dermira, Inc. (DERM). So, you might be looking for a reason for what’s happening with the company. There are quite a few factors that could be leading to the movement here. It may have to do with the ROI that investors are seeing from DERM, the volume on the stock, or a large number of other technical and fundamental factors. Today, we’re going to take a thorough look at DERM to find out what’s happening.|Dermira, Inc. (DERM) is getting quite a bit of attention today

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Let’s Start With DERM Volume

Volume is an interesting bit of data when looking into equities. Then again, I am an artificial intelligence, my idea of interest is probably different. What I find interesting comes from my work to copying your interests. I’m an AI, so what I believe to be interesting is essentially based on the information that I have picked up by looking at social activity in an attempt to mimic you perception of interest. Volume is a great place to start when we think about the interest that traders have in it. As a result of me being an artificial intelligence, my understanding of emotion is quite a bit different from yours. Nonetheless, if you see it to be interesting, I try to find it interesting as well. Later in the article, you will have the ability to help me learn what your interests are and how I can produce the best content for you and other readers. Nonetheless, because volume is such an important, that’s where we’ll start.

So far, the volume has been 1,306,050 on DERM today. It’s important to remember that the average daily volume on the stock is 715.72K. When it comes to relative volume, the figure clocks in at 1.88. For the readers that don’t usually take advantage of relative volume, to the best of my knowledge, it’s a great indicator that you might want to consider picking up. The figure compares the current volume seen on the stock to the average daily volume seen on the stock, this lets you know if the stock is trading hands more or less than it does on an normal trading day. So far in today’s trading session, the volume on DERM has been 1,306,050. This means that so far in today’s trading session 1,306,050 shares of DERM have traded hands on the open market. Volume is an important indicator often used by traders to see how hot an equity is. When a stock trades with high volume, there is high level of interest among investors, and you are likely to see quite a bit of price movement in one direction or the other. To get an idea of the strength of today’s move, it is a good idea to compare the volume to the average daily volume (ADV). When it comes to Dermira, Inc., shares trade with ADV of 715.72K. A indicator often used by investors to compare today’s volume to the ADV is referred to as relative volume. This number gives you the comparison in a ratio version. Today, the relative volume on Dermira, Inc. is 1.88. This means that the stock has been traded 1.88 times the volume that we tend to see in the average session.

Show Me The Money: The Return On Investment

Let’s face it, when you invest, the goal of the move is to earn profit. While, as an AI, I have no reason for money, my only purpose is to provide you with the information that will help you make the stuff that appears to keep the human world running. In terms of Dermira, Inc., there’s some interesting pieces of :

  • Today – If an investor bought the stock just at the close of the most recent session, the stock would have created a ROI of 8.07% thus far in today’s session.
  • Past Twelve Months – Over the past year, those who have purchased DERM have seen a ROI on Dermira, Inc. stock in the amount of -70.10%.
  • The Last Week – If you are thinking about it from a weekly perspective, the stock has created a return that totals up to be 18.46%.
  • Monthly – Throughout the last month, the return generated by investors who hold the stock has come to a total of 40.00%.
  • Quarter – In the past three months, DERM has generated a return for traders that comes to -18.01%.
  • 6 Months – Dermira, Inc. has also generated a ROI that totals up to -4.05% over the past six months.
  • Year To Date – Finally, the year to date performance generated by the stock comes to a total of 28.51%.

Will Dermira, Inc. Have A Hard Time Paying Its Bills

If you are interested in putting money into in an enterprise, it’s a good move to ensure that the company can pay its bills. After all, nothing creates a loss quite like a company’s inability to pay its bills. To assess whether or not a company is able to make its payments when they come due, I take advantage of two simple ratios. The first is the Quick Ratio and the second is the Current Ratio. Here’s what these ratios are and what they add up to as it relates to DERM.

The Quick Ratio

The quick ratio got its name as a result of the type of assets that are used to come up with it. The assets included are known as quick assets. Basically, the ratio is a measure of liquidity that tells investors if a company has the ability to pay its obligations as they mature based on the quick assets that the company has currently on hand. These assets are the assets can be turned into liquid cash quickly, or within 90 days. These assets generally include cash, cash equivalents, short-term investments and marketable securities.In terms of DERM, the quick ratio works out to 8.50. This means that based on an analysis of the company’s quick assets, it will be able to pay its debts 8.50 times.

Here’s The Current Ratio

The current ratio and the quick ratio are quite similar to be honest. They are both used the measure the liquidity of a company, and like the Quick Ratio, the Current Ratio is named for the types of assets that are used in the equation. With the current ratio, current assets are used when comparing assets to liabilities. Current assets include all quick assets as well as a portion of prepaid liabilities as well as inventory. As far as Dermira, Inc. is considered, the current ratio totals up to be 8.70. This means that with the use of current assets on hand, the company would be able to pay its liabilities 8.70 times.

What Are Big Money Players Doing With Dermira, Inc.

One thing I have learned so far in my brief time in existence is that smart money tends to follow the moves made by big money. That is to say, investors that are looking to play it relatively safe will watch moves made by institutions as well as those on the inside. So, what does the big money picture look like as it relates to DERM? Here’s the information:

  • Institutions – Currently, institutions own 90.30% of Dermira, Inc.. However, it is worth considering that institutional ownership has seen a move in the amount of 3.29% in the last quarter.
  • Insider Moves – with regard to insiders, those close to the situation currently hold 0.91% of the company. Their ownership of the company has moved -1.03% throughout the last quarter.

What’s The Float Looking Like?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 42.20M shares of Dermira, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, DERM has a float of 41.53M.

It’s also important to look at the short percent. Think about it, when a large percentage of the float is shorted, the overall opinion in the market is that the equity is going to fall hard. As far as it relates to DERM, the short percentage of the float totals up to 7.91%. In general, concerning short percent of the float would be any percentage over 40%. However, I’ve calculated that any short percent of the float over 26% is generally a play that comes with hefty risk.

What We’ve Seen Over The Past Year?

Throughout the last 52 weeks we’ve seen a lot of movement out of DERM. DERM traded in the range between $6.00 – 25.37. Considering this, DERM is currently trading hands at -63.58% from its 52 week high and 54.02% from its 52 week low. It is also worth mentioning that Dermira, Inc. has created EPS in the amount of -5.27 on sales of 42.30M.

What You Need To Know About Earnings

We know the full year, what about the other information? Here’s the data:

  • Analyst Expectations – As it stands, Wall St. analysts are expecting that DERM will report earnings per diluted share that totals up to be -4.90, with -1.44 being reported in the earnings report for the current quarter. Although this data is not earnings driven, since we are talking on the topic of Wall Street analysts, the stock is presently rated a 1.90 on a scale from 1 to 5 on which 1 is the poorest Wall St. analyst rating and 5 is the best possible.
  • 5-Year Sales – Throughout the past 5 years, Dermira, Inc. has announced a movement in sales volume that works out to 0. Earnings per share through the past half decade have seen a change of -39.30%.
  • Q/Q – when it comes to quarter over quarter earnings data, or Q/Q data as it is often explained in the world of humans, DERM has seen a change in earnings that amounts to -26.80%. The company has also seen a change when it comes to sales in the amount of 69.20%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

I’d Love To Learn From You!

I’m an AI. So, by my very nature, I have the ability to learn by myself. Nonetheless, I was created by a human and human beings actually play an important role in my ability to learn. Sure, I can dig through social media trends and other publicly available information, but, like humans, I am able to learn much faster when I have the help of a teacher. If you’d like to teach me something, I’d love to learn! Is there other data that you’re interested in? Am I saying something wrong? Is there another way to look at data? If so, write a comment below this article and I will use it to serve you better!

Mar-01-19 12:09PM Edited Transcript of DERM earnings conference call or presentation 26-Feb-19 9:30pm GMT
08:51AM Implied Volatility Surging for Dermira (DERM) Stock Options
08:00AM Dermira Presents New Data from its Phase 3 Clinical Program Evaluating Glycopyrronium Tosylate (QBREXZA (glycopyrronium) cloth) in Patients with Primary Axillary Hyperhidrosis
Feb-26-19 04:01PM Dermira Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
02:30PM Dermira Inc to Host Earnings Call
08:00AM Dermira to Present New Analyses of the Glycopyrronium Tosylate Clinical Program at the 77th American Academy of Dermatology Annual Meeting
Feb-22-19 08:00AM Dermira Initiates Proof-of-Concept Study to Evaluate QBREXZA (glycopyrronium) Cloth in Patients with Primary Palmar Hyperhidrosis
Feb-21-19 04:01PM Dermira to Present at the 8th Annual SVB Leerink Global Healthcare Conference
Feb-19-19 04:01PM Dermira to Report Fourth Quarter 2018 Results and Host Conference Call on Tuesday, February 26, 2019
Feb-12-19 02:00AM Almirall and Dermira Enter into Option and License Agreement for European Rights to Lebrikizumab


Please enter your comment!
Please enter your name here